People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ATS Parent, LLC | — | Other | Series C | $63.4M | $798.6M | 2022 |
| Pharmetrics Specialty Group of San Antonio, LLC | — | Pharmaceuticals | Pre-Seed | $350K | $490K | — |
Ryan Myers at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ryan Myers on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JACOB MICHEL | 1 | 12 |
| JOHN EADES | 1 | 11 |
| PETER DAY | 1 | 11 |
| DEAN PEDALINO | 1 | 10 |
| ROBERT STROUD | 1 | 9 |
| DAN LAMAR | 1 | 9 |
| Paul Davis | 1 | 7 |
| David Haddad | 1 | 2 |
| Justin Kulla | 1 | 1 |
| Donald Gorski | 1 | 1 |
| Molly Tschang | 1 | 1 |
| Ken Sobaski | 1 | 1 |
| Jonathan Tanenbaum | 1 | 1 |
| Troy Pritchett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.